These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22263341)

  • 1. [PET-CT in the oncological translational platforms].
    Carreras Delgado JL
    An R Acad Nac Med (Madr); 2010; 127(3):435-42; discussion 442-4. PubMed ID: 22263341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New PET imaging agents in the management of solid cancers.
    Garcia C; Gebhart G; Flamen P
    Curr Opin Oncol; 2012 Nov; 24(6):748-55. PubMed ID: 22913970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-peptidyl (18)F-labelled PET tracers as radioindicators for the noninvasive detection of cancer.
    Wagner S; Kopka K
    Recent Results Cancer Res; 2013; 187():107-32. PubMed ID: 23179879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/CT imaging in cancer: current applications and future directions.
    Farwell MD; Pryma DA; Mankoff DA
    Cancer; 2014 Nov; 120(22):3433-45. PubMed ID: 24947987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET/Computed Tomography Using New Radiopharmaceuticals in Targeted Therapy.
    Sharma P; Kumar R; Alavi A
    PET Clin; 2015 Oct; 10(4):495-505. PubMed ID: 26384596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, appropriateness, and consequences of recommendations for additional imaging tests in oncological PET/CT reports.
    Shinagare AB; Shyn PB; Sadow CA; Wasser EJ; Catalano P
    Clin Radiol; 2013 Feb; 68(2):155-61. PubMed ID: 22892243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET-specific parameters and radiotracers in theoretical tumour modelling.
    Jennings M; Marcu LG; Bezak E
    Comput Math Methods Med; 2015; 2015():415923. PubMed ID: 25788973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose CT and contrast-medium CT in hybrid PET/CT systems for oncologic patients.
    Chiaravalloti A; Rubello D; Chondrogiannis S; Giammarile F; Colletti PM; Schillaci O
    Nucl Med Commun; 2015 Sep; 36(9):867-70. PubMed ID: 25850718
    [No Abstract]   [Full Text] [Related]  

  • 9. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
    Salem SS; Shahin MA
    Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary experience with 18f-fluoro-deoxy-glucose positron emission tomography/computed tomography in pediatric oncology patients.
    Odalović S; Sobić-Saranović D; Pavlović S; Grozdić I; Saranović D; Petrović M; Milovanović A; Petrasinović Z; Djurić-Stefanović A; Obradović V
    Acta Chir Iugosl; 2011; 58(4):67-73. PubMed ID: 22519195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriate indications for positron emission tomography/computed tomography, 2015.
    Vorster M; Doruyter A; Brink A; Mkhize S; Holness J; Malan N; Nyakale N; Warwick JM; Sathekge M;
    S Afr Med J; 2015 Oct; 106(1 Pt 2):105-22. PubMed ID: 26792318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases.
    Pantaleo MA; Nannini M; Lopci E; Castellucci P; Maleddu A; Lodi F; Nanni C; Allegri V; Astorino M; Brandi G; Di Battista M; Boschi S; Fanti S; Biasco G
    Int J Oncol; 2008 Sep; 33(3):443-52. PubMed ID: 18695872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Positron emission tomography 2013 in Germany. Results of the query and current status].
    Kotzerke J; Oehme L; Grosse J; Hellwig D;
    Nuklearmedizin; 2015; 54(2):53-9. PubMed ID: 25650552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
    Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
    Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of FDG-PET/CT in the post-treatment evaluation of endometrial carcinoma: a comparison of PET/CT findings with conventional imaging and CA 125 as a tumour marker.
    Ozcan Kara P; Kara T; Kaya B; Kara Gedik G; Sari O
    Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):257-60. PubMed ID: 23067527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From PET/CT to PET/MRI: advances in instrumentation and clinical applications.
    Hu Z; Yang W; Liu H; Wang K; Bao C; Song T; Wang J; Tian J
    Mol Pharm; 2014 Nov; 11(11):3798-809. PubMed ID: 25058336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG PET/CT in oncology: "raising the bar".
    Patel CN; Goldstone AR; Chowdhury FU; Scarsbrook AF
    Clin Radiol; 2010 Jul; 65(7):522-35. PubMed ID: 20541652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.